Roderick Wong
@Rtw Investments, Lp
Latest period2024 - Q3ReportedManaged Assets$6.911BTotal holdings68
Assets growth rate7%Assets growth rate (2-Q avg)1.18%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Rtw Investments, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 68 positions.
Assets under management
The assets under management (AUM) of Rtw Investments, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.911B in assets, with a quarterly growth rate of 7% and a 2-quarter average growth rate of 1.18%. The portfolio is managed by Roderick Wong, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
MDGLMadrigal Pharmaceuticals Inc
| 6.13% | $423.1M 1.994M shares@ $212.22 avg price | Increased 4.07% |
AXSMAxsome Therapeutics Inc
| 5.45% | $376.515M 4.19M shares@ $89.88 avg price | Decreased -9.59% |
RNAAvidity Biosciences Inc
| 5.41% | $373.543M 8.133M shares@ $45.93 avg price | Decreased -7.65% |
ARGXArgenx Se
| 5.14% | $354.753M 654,430 shares@ $542.08 avg price | |
NTRANatera Inc
| 4.77% | $329.222M 2.593M shares@ $126.96 avg price | |
RCKTRocket Pharmaceuticals Inc
| 4.73% | $326.693M 17.688M shares@ $18.48 avg price | |
PTCTPtc Therapeutics Inc
| 3.97% | $274.285M 7.393M shares@ $37.11 avg price | |
DYNDyne Therapeutics Inc
| 3.55% | $244.926M 6.819M shares@ $35.93 avg price | Increased 6.76% |
PTGXProtagonist Therapeutics Inc
| 3.54% | $244.175M 5.426M shares@ $45.0 avg price | Increased 2.65% |
BRKRBruker Corp
| 3.48% | $240.406M 3.481M shares@ $69.06 avg price | Increased 1.08% |